Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis

BMC Complementary and Alternative Medicine

Volumn 14, Issue 1, 2014, Pages

  Tao, Yan Yan ^a   Yan, Xiu Chuan ^a   Zhou, Tao ^a   Shen, Li ^a   Liu, Zu Long ^a   Liu, Cheng Hai ^a,b,c,d  

^a SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d Shanghai Municipal Education Commission   (China)

Author keywords

Apoptosis; Fuzheng Huayu recipe; Hepatic stellate cell; Hepatocyte; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; ASPARTATE AMINOTRANSFERASE; CELL NUCLEUS DNA; CHINESE DRUG; COLLAGEN TYPE 1; FUZHENG HUAYU; HERBACEOUS AGENT; HYDROXYPROLINE; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; ACTA2 PROTEIN, MOUSE; ACTIN; BAX PROTEIN, MOUSE; BCL2 PROTEIN, MOUSE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CARBON TETRACHLORIDE; ENZYME INHIBITOR; PEPTIDE CHLOROMETHYL KETONE; TNFRSF1A PROTEIN, MOUSE; ACETYLCYSTEINE; DACTINOMYCIN; SERUM ALBUMIN; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER INJURY; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; STELLATE CELL; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; LIVER; LIVER CELL; LIVER CIRRHOSIS; METABOLISM; PHYTOTHERAPY; ALBUMIN BLOOD LEVEL; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; IN VIVO STUDY;

ACTINS; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARBON TETRACHLORIDE; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; HEPATIC STELLATE CELLS; HEPATOCYTES; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; MICE, INBRED C57BL; PHYTOTHERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84964315610     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-449.     Document Type: Article

References (38)

1. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008,134(6):1655-1669.10.1053/j.gastro.2008.03.003.
2. Friedman SL: Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004,1(2):98-105.10.1038/ncpgasthep0055.
3. Jiang JX, Mikami K, Venugopal S, Li Y, Torok NJ: Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol 2009,51(1):139-148.10.1016/j.jhep.2009.03.024.
4. Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA, Mehal WZ: Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 2007,46(5):1509-1518.10.1002/hep.21867.
5. Friedman SL: Evolving challeges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010,7(8):425-436.10.1038/nrgastro.2010.97.
6. Fallowfield JA: Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2011,300(5):G709-G715.10.1152/ajpgi.00451.2010.
7. Du B, You S: Present situation in preventing and treating liver fibrosis with TCM drugs. J Tradit Chin Med 2001,21(2):147-152.
8. Zhang J, Xu L: [Advances of mechanism research on treatment of experimental liver fibrosis with traditional Chinese medicine]. Zhong Xi Yi Jie He Xue Bao 2003,1(2):142-145.10.3736/jcim20030218.
9. Zhang B, Wang LT: [Progress in experimental study on inhibitory effect of traditional Chinese medicine on liver fibrosis]. Zhong Xi Yi Jie He Xue Bao 2006,4(2):206-210.10.3736/jcim20060221.
10. Yang T, Shen DP, Wang QL, Tao YY, Liu CH: Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components. J Ethnopharmacol 2013,148(2):691-700.10.1016/j.jep.2013.05.031.
11. Cheung KF, Ye DW, Yang ZF, Lu L, Liu CH, Wang XL, Poon RT, Tong Y, Liu P, Chen YC, Lau GK: Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2009,124(1):142-150.10.1016/j.jep.2009.03.005.
12. Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J: [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]. Zhong Xi Yi Jie He Xue Bao 2003,1(2):89-98.10.3736/jcim20030204.
13. Liu P, Liu C, Xu LM, Hu YY, Xue HM, Liu CH, Zhang ZQ: Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol 1998,4(4):348-353.
14. Liu P, Liu C, Hu YY: [Effect of fuzheng huayu recipe in treating posthepatitic cirrhosis]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1996,16(8):459-462.
15. Liu C, Hu Y, Xu L, Liu P: Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med 2009, 4:12-22.10.1186/1749-8546-4-12.
16. Liu C, Wang X, Liu P: [Serapharmacological effect of fuzheng huayu 319 Decoction on expression of type I collagen and transforming growth factor beta 1 in hepatic stellate cells]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999,19(7):412-414.
17. Zhou T, Yan X, Chen Q, Tao Y, Liu C: [Effect of Fuzheng huayu decoction on hepatocytic apoptosis and necrosis on acute liver injury due to LPS in mice]. Drug Evaluation 2008,5(5):204-208.
18. Brunt EM: Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000,31(1):241-246.10.1002/hep.510310136.
19. Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL: Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 2004,127(3):870-882.10.1053/j.gastro.2004.04.062.
20. Xie H, Tao Y, Lv J, Pinsaa L: Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats. Evid Based Complement Alternat Med 2013, 972863:972863.
21. Jamall IS, Finelli VN, Que Hee SS: A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 1981,112(1):70-75.10.1016/0003-2697(81)90261-X.
22. Yan X, Zhou T, Tao Y, Wang Q, Liu P, Liu C: Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways. Exp Biol Med 2010,235(5):623-632.10.1258/ebm.2009.009293.
23. Kitamura T, Itoh M, Noda T, Matsuura M, Wakabayashi K: Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Int J Cancer 2004,109(4):576-580.10.1002/ijc.20012.
24. Oberhammer F, Bursch W, Tiefenbacher R, Froschl G, Pavelka M, Purchio T, Schulte-Hermann R: Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology 1993,18(5):1238-1246.10.1002/hep.1840180533.
25. Hatano E: Tumor necrosis factor signaling in hepatocyte apoptosis. J Gastroenterol Hepatol 2007,22(Suppl 1):S43-S44.
26. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ: Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000,106(9):1127-1137.10.1172/JCI9914.
27. Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K, Brandes RP, Devaraj S, Torok NJ: Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med 2012,53(2):289-296.10.1016/j.freeradbiomed.2012.05.007.
28. Canbay A, Friedman S, Gores GJ: Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004,39(2):273-278.10.1002/hep.20051.
29. Kim TH, Venugopal SK, Zhu M, Wang SS, Lau D, Lam KS, Clemens DL, Zern MA: A novel small molecule, LAS-0811, inhibits alcohol-induced apoptosis in VL-17A cells. Biochem Biophys Res Commun 2009,379(4):876-881.10.1016/j.bbrc.2008.12.133.
30. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ: The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 2004,308(3):1191-1196.
31. Hoglen NC, Chen LS, Fisher CD, Hirakawa BP, Groessl T, Contreras PC: Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-te trafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor. J Pharmacol Exp Ther 2004,309(2):634-640.10.1124/jpet.103.062034.
32. Eghbali-Fatourechi G, Sieck GC, Prakash YS, Maercklein P, Gores GJ, Fitzpatrick LA: Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis. Endocrinology 1996,137(5):1894-1903.
33. Galicia-Moreno M, Rodriguez-Rivera A, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P: N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur J Gastroenterol Hepatol 2009,21(8):908-914.10.1097/MEG.0b013e32831f1f3a.
34. Saini U, Gumina RJ, Wolfe B, Kuppusamy ML, Kuppusamy P, Boudoulas KD: Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation. J Cell Biochem 2013, 114:2612-2623.10.1002/jcb.24609.
35. Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W: Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett 1997,410(1):96-106.10.1016/S0014-5793(97)00553-X.
36. Malhi H, Gores GJ, Lemasters JJ: Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006,43(2 Suppl 1):S31-S44.
37. Cory S, Huang DC, Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003,22(53):8590-8607.10.1038/sj.onc.1207102.
38. Takehara T, Tatsumi T, Suzuki T, Rucker EB 3rd, Hennighausen L, Jinushi M, Miyagi T, Kanazawa Y, Hayashi N: Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 2004,127(4):1189-1197.10.1053/j.gastro.2004.07.019.